title: Reply: To PMID 26203758.
authors.affiliation: Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, University of Toronto, Toronto, Canada.
authors.forename: Uri
authors.initials: U
authors.lastname: Elbaz
authors.forename: Kamiar
authors.initials: K
authors.lastname: Mireskandari
authors.forename: Carl
authors.initials: C
authors.lastname: Shen
authors.forename: Asim
authors.initials: A
authors.lastname: Ali
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D016510:Corneal Neovascularization / Q000628:therapy*; D004564:Electrocoagulation / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab